Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.86 USD | +0.93% | +0.59% | -18.12% |
01:37pm | ABL Bio, BMS Collaborate on Gastric Cancer Treatment Trial | MT |
Jun. 07 | Geron shares surge after U.S. FDA approves blood disorder drug | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.12% | 84.08B | |
+47.19% | 765B | |
-6.09% | 354B | |
+19.88% | 331B | |
+9.35% | 299B | |
+19.02% | 248B | |
-1.80% | 219B | |
+10.93% | 216B | |
+5.01% | 164B | |
-2.61% | 162B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Societe Generale Downgrades Bristol-Myers Squibb to Hold From Buy, Cuts Price Target to $51 From $85